Latest news
Loading news…
Stratos Genomics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Seattle, Washington, United States Founded 2007 51-100 employees For Profit
Stratos Genomics develops Sequencing by Expansion (SBX), a single-molecule detection process that enables whole-genome sequencing.
Stratos Genomics was acquired by Roche in 2020.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
6
Patents
21
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $100M to $500M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Active products
- 14
- Patents granted
- 21
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
Company Info
- Founded
- 2007
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 20
- HQ
- Seattle, Washington, United States
- Region
- Greater Seattle Area, West Coast, Western US
- Exit date
- May 22, 2020
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.7
- Trend (90d)
- -1
6
professional contacts at Stratos Genomics
Contact execs at Stratos Genomics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Stratos Genomics
Loading news…
FAQs about Stratos Genomics
People who checked this page also checked these
Browse the full Acquirezy directory.